BIOS BioSenic S.A.

0.0022USD0.0020 EUR · EBR0.00%Mkt Cap: 1.43M USDP/E: —

BioSenic S.A., a biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France. The company offers arsenic trioxide (ATO) and oral arsenic trioxide (O…

Key Statistics

Company
Market Cap1.43M USD
Enterprise Value4.11M USD
Revenue (TTM)-2.84M USD
Gross Profit-3.40M USD
Net Income (TTM)-31.56M USD
Revenue/Share-0.0066 USD
Last Price0.0022 USD
Fiscal Year EndDec 2024
MR QuarterJun 2026
Employees7
CountryBE
SectorHealthcare
IndustryBiotechnology
ISINBE0974280126
Valuation
P/E (Trailing)—
P/E (Forward)-0.04
PEG—
EV/EBITDA-0.73
EV/Revenue-1.45
P/S-0.50
P/B-2.00
EPS (TTM)-0.02 USD
EPS (Forward)-0.05 USD
52W Range
0.002025% of range0.0029
52W High0.0029 USD
52W Low0.0020 USD
Profitability
Gross Margin0.00%
Oper. Margin210.15%
EBITDA Margin0.00%
Profit Margin0.00%
ROE125.60%
ROA-301.06%
ROIC-131.83%
ROCE—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.81M USD
CapEx (TTM)—
FCF Margin140.94%
FCF Yield-279.78%
Net Debt2.68M USD
Net Debt/EBITDA-0.48
Net Debt/FCF—
Balance Sheet
Debt/Equity-1.23
Current Ratio0.53
Quick Ratio0.50
Book Value/Sh-0.0011 USD
Cash/Share0.00 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.652.86M
Float603.17M
Insiders7.61%
Institutions0.00%
Technical
SMA 500.0022 (+0.0%)
SMA 2000.0023 (-5.3%)
Beta-1.58
S&P 52W Chg12.00%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)39.4
MACD0.0000
MACD Signal0.0000
MACD Hist.+0.0000
BB Upper0.0022 USD
BB Middle0.0022 USD
BB Lower0.0022 USD
BB Width0.00%
ATR (14)0.0000 USD
Vol Ratio (20d)—

About BioSenic (EBR: BIOS)

›

BioSenic (EBR: BIOS) is listed on Euronext Brussels, where its shares trade in EUR. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 7 employees.

The shares were at 0.0020 EUR on 18 November 2026, down 16.7% over 52 weeks. Its 52-week range is 0.0018 EUR to 0.0026 EUR: the price is 23.1% below the high and 11.1% above the low.

Its market capitalisation is 1.31M EUR.

BioSenic reports return on equity of 125.6% and an operating margin of 210.1%.

Its debt exceeds its cash by 2.44M EUR. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health.